These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 12484378)

  • 1. PET scans improve management decisions, reduce unnecessary surgery in recurrent colorectal cancer.
    Rollins G
    Rep Med Guidel Outcomes Res; 2002 May; 13(9):7-9. PubMed ID: 12484378
    [No Abstract]   [Full Text] [Related]  

  • 2. FDG-PET improves the staging and selection of patients with recurrent colorectal cancer.
    Lonneux M; Reffad AM; Detry R; Kartheuser A; Gigot JF; Pauwels S
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):915-21. PubMed ID: 12111132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of radioimmunoscintigraphy on the management of recurrent colorectal cancer.
    Lunniss PJ; Skinner S; Britton KE; Granowska M; Morris G; Northover JM
    Br J Surg; 1999 Feb; 86(2):244-9. PubMed ID: 10100796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with 99mTc scintigraphy.
    Sirisriro R; Boonkitticharoen V; Kraiphibul P; Ratanatharathorn V; Sumboonnanon K; Kanjanapitak A; Kuhapremma T; Sritara C; Puchinda D; Chouplywech P; Jalayondeja V; Pekanan P; Rochanawutanon M; Intaramarn C; Ayudhya AN; Chokesuwathana P
    Hepatogastroenterology; 2000; 47(32):405-13. PubMed ID: 10791201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of positron emission tomography in the management of recurrent colorectal cancer: a review.
    Watson AJ; Lolohea S; Robertson GM; Frizelle FA
    Dis Colon Rectum; 2007 Jan; 50(1):102-14. PubMed ID: 17115340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of 18F-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan.
    Shen YY; Liang JA; Chen YK; Tsai CY; Kao CH
    Hepatogastroenterology; 2006; 53(69):348-50. PubMed ID: 16795969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unnecessary surgery can be avoided by judicious use of PET/CT scanning in colorectal cancer patients.
    Amin A; Reddy A; Wilson R; Jha M; Miranda S; Amin J
    J Gastrointest Cancer; 2012 Dec; 43(4):594-8. PubMed ID: 22552946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of recurrent colorectal cancer with positron emission tomography.
    Haji A
    Br J Hosp Med (Lond); 2007 Nov; 68(11):580-3. PubMed ID: 18087843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of (18)F-FDG dual-head gamma-camera coincidence imaging in recurrent or metastatic colorectal carcinoma.
    Even-Sapir E; Lerman H; Figer A; Rabau M; Livshitz G; Inbar M; Gutman M
    J Nucl Med; 2002 May; 43(5):603-9. PubMed ID: 11994521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography affects surgical management in recurrent colorectal cancer patients.
    Desai DC; Zervos EE; Arnold MW; Burak WE; Mantil J; Martin EW
    Ann Surg Oncol; 2003; 10(1):59-64. PubMed ID: 12513962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of FDG-PET on the management algorithm for recurrent colorectal cancer.
    Arulampalam T; Costa D; Visvikis D; Boulos P; Taylor I; Ell P
    Eur J Nucl Med; 2001 Dec; 28(12):1758-65. PubMed ID: 11734912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New imaging techniques in colorectal cancer.
    Tempero M; Brand R; Holdeman K; Matamoros A
    Semin Oncol; 1995 Oct; 22(5):448-71. PubMed ID: 7570057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunoscintigraphy of a colorectal tumor recurrence using a 99mTc-labeled anti-CEA-antibody].
    Rilinger N; Niemann H; Halbfass HJ
    Rontgenpraxis; 1989 Jul; 42(7):245-7. PubMed ID: 2756446
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].
    Kula Z; Szefer J; Zuchora Z; Romanowicz G; Pietrzak T
    Pol Merkur Lekarski; 2004; 17 Suppl 1():63-6. PubMed ID: 15603351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent colorectal cancer.
    Hung GU; Shiau YC; Tsai SC; Chao TH; Ho YJ; Kao CH
    Anticancer Res; 2001; 21(2B):1375-8. PubMed ID: 11396217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative radioimmunolocalization of colorectal cancer by radiolabeled monoclonal antibodies.
    Badellino F; Percivale P; Meszaros P; Gipponi M; Bartolomeo S; Nicolo G; Spina B; Schenone F; Bertoglio S
    J Surg Oncol Suppl; 1991; 2():86-91. PubMed ID: 1892537
    [No Abstract]   [Full Text] [Related]  

  • 17. Colorectal cancer. Diagnosis of recurrence.
    Romano G; Belli G; Rotondano G
    Gastrointest Endosc Clin N Am; 1995 Oct; 5(4):831-41. PubMed ID: 8535632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of 2-fluoro-2-deoxy-D-glucose positron emission tomography in managing patients of colorectal cancer with unexplained carcinoembryonic antigen elevation at different levels.
    Liu FY; Chen JS; Changchien CR; Yeh CY; Liu SH; Ho KC; Yen TC
    Dis Colon Rectum; 2005 Oct; 48(10):1900-12. PubMed ID: 15991059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of positron emission tomography (PET) in the detection of local recurrence and metastases of colorectal cancer].
    Kanyári Z; Orosz L; Juhász B; Tanyi M; Németh E; Trón L; Damjanovich L; Lukács G; Kálvin B
    Magy Seb; 2005 Jun; 58(3):179-83. PubMed ID: 16167472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incremental value of CT in PET/CT of patients with colorectal carcinoma.
    Kamel IR; Cohade C; Neyman E; Fishman EK; Wahl RL
    Abdom Imaging; 2004; 29(6):663-8. PubMed ID: 15162236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.